The NCPE partner with IPPOSI to deliver the Patient Education Programme in Health Innovation. The programme was conceived through IPPOSI’s experience with the European Patients Academy on Therapeutic Innovation (EUPATI), in partnership with University College Dublin Clinical Research Centre, the Health Products Regulatory Authority and the NCPE. The purpose of the programme is to empower patients with knowledge and understanding of the medicines development and regulatory processes, enabling patient advocates to work effectively with Irish and EU-level health research and technology partners, agencies and authorities.
The course consists of a mixture of e-learning and face-to-face workshops and seminars. Three modules are delivered on the course:
- Understanding Clinical Trials,
- Pre- and post-authorisation of medicines and regulation of medical devices in Europe, and
- Principles and Practices of Health Technology Assessment.
The NCPE coordinate and deliver the HTA module of the course. Following completion of the module on HTA, participants are able to understand why HTA and economic evaluation are important for health policy decisions, understand what type of information contributes to a better understanding of clinical benefit, and describe the technology reimbursement process in Ireland, and how patient organisations can be involved in the process.
See www.ipposi.ie for further information, including details of how to apply for a place on the course.
